Bioclinic
Who owns Bioclinic?
Bioclinic is a French Healthcare company, now owned by IDIA Capital Investissement, which acquired it in 2018 from Galia Gestion and Azulis Capital.
Hand-verified · updated 2026-04-21
Open JSON · CC-BY
Key facts
- ·Fully exited in 2018 to Idia Capital Investissement, Amundi Private Equity Funds, Socadif and Andera Partners.
- ·Average hold across 2 realized cycles: 6 years.
Ownership history
2 ownership periods · co-invest detected · 1 lender on file
Galia Gestion sold BIOCLINIC to Idia Capital Investissement, Amundi Private Equity Funds, Socadif and Andera Partners in 2018 after 6 years.
Azulis Capital sold Bioclinic to IDIA Capital Investissement in 2018 after 6 years.
More from Azulis MMF IV
Other portfolio companies in the same fund.
France· 2014
France· 2014
France· 2014France· 2013France· 2012
France· 2011More PE-backed in Healthcare
Comparable healthcare deals from other GPs.
US
Questions
Who owns Bioclinic?
Bioclinic is now owned by IDIA Capital Investissement, which acquired it in 2018 from Galia Gestion and Azulis Capital.
When did IDIA Capital Investissement acquire Bioclinic?
IDIA Capital Investissement acquired Bioclinic in 2018, buying from Galia Gestion and Azulis Capital.
Who did Bioclinic sell to?
Andera Partners sold Bioclinic to Inovie in 2022 (Trade Sale). Galia Gestion sold Bioclinic to Idia Capital Investissement, Amundi Private Equity Funds, Socadif and Andera Partners in 2018 (Secondary). Azulis Capital sold Bioclinic to IDIA Capital Investissement in 2018 (Secondary).
Who has owned Bioclinic over time?
Bioclinic has been through 3 private-equity ownership periods: Galia Gestion · via Galia Investissements 2 · 2012–2018 · sold to Idia Capital Investissement, Amundi Private Equity Funds, Socadif and Andera Partners · (Secondary); Azulis Capital · via Azulis MMF IV · 2012–2018 · sold to IDIA Capital Investissement · (Secondary); Andera Partners · via Acto Mezzanine III · 2018–2022 · sold to Inovie · (Trade Sale).